3173 results for «598»
3173 results
DCB in variable day-to-day clinical scenarios
07 Oct 2022 – From AICT-AsiaPCR 2022
In this AICT AsiaPCR 2022 session 4 cases will be discussed that will enable you to learn more about drug-coated balloons and the variable indications for their use in daily practice, or techniques for using them in different lesion settings.
Treatment of calcified lesions
07 Oct 2022 – From AICT-AsiaPCR 2022
Consider a 66-year-old man, hypertensive and diabetic for 10 years, with history of recurrent substernal chest pain and exertional dyspnea, who presented with easy fatigability and shortness of breath, or a 72-year-old man on dialysis who presented with STEMI and severe calcified stenosis of LAD/DI bifurcation,...
Treatment of severe tricuspid regurgitation - Session with LIVE case
07 Oct 2022 – From AICT-AsiaPCR 2022
Watch the LIVE case management of an 84-year-old male patient, diabetic, hypertensive, with previous PCI on LAD and ICD, permanent AF, and exertional dyspnea for 6 months and learn more about severe tricuspid regurgitation pathology and treatment.
CTO-PCI
07 Oct 2022 – From AICT-AsiaPCR 2022
Consider a 53-year-old man with a strong family history of MI, a history of exertion angina with cycling and dyslipidemia, or a 76-year-old male patient with hypertension, type 2 diabetes, previous CABG (2017), cholecystectomy (2018), left carotid endarterectomy (2018), left leg intervention (2018), and mild aortic...
Complex PCI with left ventricular support - Session with LIVE case
07 Oct 2022 – From AICT-AsiaPCR 2022
Look at this case of a 73-year-old man, heavy smoker, with hypertension, type 2 DM, and hyperlipidemia, who recently suffered class III effort-related angina and non-ST elevation MI, who presented with a totally occluded RCA, ulcerated LM, occluded LAD, and stenotic LCx, and study LIVE a complex PCI...
Surgical turndowns interventions and outcomes
07 Oct 2022 – From AICT-AsiaPCR 2022
Through this AICT AsiaPCR 2022 session, view a variety of case presentations and hear your peers discuss them to learn how to successfully manage high-risk PCI procedures.
How to avoid and manage complications - Rupture and perforation
In this case-based discussion, learn with experts how to avoid major complications during PCI such as distal vessel perforation and mid vessel rupture, and through algorithms, how to manage them in case they occur.
Tips, tricks and complications
08 Oct 2022 – From AICT-AsiaPCR 2022
Through 4 case examples, this discussion with experts will help you understand management strategies and problem solving for common and rare interventional complications.
How to deal with calcified coronaries
08 Oct 2022 – From AICT-AsiaPCR 2022
In this session, learn with experts about practical decisional algorithms to select the most appropriate tool in function of calcification severity and extension, and discover the contemporary tools and techniques for optimal plaque modification.
AICT-AsiaPCR 2022's best clinical case and best abstract Awards
08 Oct 2022 – From AICT-AsiaPCR 2022
Percutaneous closure of a bleeding mycotic coronary artery aneurysm, superior vena cava aneurysm closed with an atrial septal defect device… Discover the best clinical cases and abstracts which were presented during AICT-AsiaPCR 2022.
AICT-AsiaPCR 2022 Closing Ceremony
08 Oct 2022 – From AICT-AsiaPCR 2022
In this Closing Ceremony, Ashok Seth thanks all participants, Programme Committee Members, Faculty members and presenters, LIVE operating teams and Industry Partners for being part of this fantastic online and onsite edition of AICT-AsiaPCR 2022, while he highlights the key moments of the course.
5-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients with aortic stenosis (Evolut Low Risk)
01 Apr 2025
Yohei Ohno provides his takeaways from the results of the Evolut Low Risk trial which was presented by Michael J. Reardon during the ACC.25 in Chicago.
Author
Harmonising optimal strategy for treatment of coronary artery diseases – bleeding risk: HOST-BR
29 Mar 2025
Daniele Giacoppo and Nicola Ammirabile provide their take on the main results of the HOST-BR trial, presented by Hyo-Soo Kim at ACC.25 in Chicago.
Author
Author
